Cerus (CERS) Share-based Compensation (2010 - 2026)
Cerus' (CERS) quarterly Share-based Compensation came in at $18.4 million in Q2 2026, up 1.3% year-over-year from $18.2 million in Q2 2025, and down 1.08% quarter-over-quarter from $18.6 million in Q1 2026.
Analysis
Cerus (CERS) Share-based Compensation (2010 - 2026) Analysis & Trends
Cerus has disclosed Share-based Compensation across 17 years of filings, most recently posting $18.4 million for Q2 2026.
- In Q2 2026, Share-based Compensation rose 1.3% year-over-year to $18.4 million; the TTM figure through Jun 2026 stood at $18.4 million (up 1.3% YoY), while the FY2025 annual figure was $22.9 million, changed 0.0% from the prior year.
- Share-based Compensation came in at $18.4 million for Q2 2026 at Cerus, down from $18.6 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $18.6 million in Q1 2026 to a low of $500000.0 in Q3 2025.
- Average Share-based Compensation over 5 years is $12.7 million, with a median of $14.5 million recorded in 2022.
- The largest YoY upside for Share-based Compensation was 32.47% in 2025 against a maximum downside of 96.35% in 2025.
- Over 5 years, Share-based Compensation stood at $7.3 million in 2022, then plunged by 32.42% to $4.9 million in 2023, then increased by 12.26% to $5.5 million in 2024, then decreased by 10.48% to $4.9 million in 2025, then jumped by 273.45% to $18.4 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $18.4 million in Q2 2026, $18.6 million in Q1 2026, and $4.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn | 18.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.40 Mn |
| Mar 31, 2026 | 18.60 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 18.16 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Dec 31, 2024 | 5.50 Mn |
| Sep 30, 2024 | 13.71 Mn |
| Jun 30, 2024 | 13.71 Mn |
| Mar 31, 2024 | 13.93 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Sep 30, 2023 | 14.53 Mn |
| Jun 30, 2023 | 14.79 Mn |
| Mar 31, 2023 | 14.90 Mn |
| Dec 31, 2022 | 7.26 Mn |
| Sep 30, 2022 | 14.50 Mn |
| Jun 30, 2022 | 16.12 Mn |
| Mar 31, 2022 | 16.02 Mn |
| Dec 31, 2021 | 6.54 Mn |
| Sep 30, 2021 | 16.10 Mn |